149 related articles for article (PubMed ID: 9316818)
1. Tissue and perfusate pharmacokinetics of melphalan in isolated perfused rat hindlimb.
Wu ZY; Smithers BM; Roberts MS
J Pharmacol Exp Ther; 1997 Sep; 282(3):1131-8. PubMed ID: 9316818
[TBL] [Abstract][Full Text] [Related]
2. The effects of perfusion conditions on melphalan distribution in the isolated perfused rat hindlimb bearing a human melanoma xenograft.
Wu ZY; Smithers BM; Parsons PG; Roberts MS
Br J Cancer; 1997; 75(8):1160-6. PubMed ID: 9099965
[TBL] [Abstract][Full Text] [Related]
3. Melphalan dosing regimens for management of recurrent melanoma by isolated limb perfusion: application of a physiological pharmacokinetic model based on melphalan distribution in the isolated perfused rat hindlimb.
Wu ZY; Smithers BM; Roberts MS
Melanoma Res; 1997 Jun; 7(3):252-64. PubMed ID: 9195565
[TBL] [Abstract][Full Text] [Related]
4. The effect of protein binding on the deep tissue penetration and efflux of dermally applied salicylic acid, lidocaine and diazepam in the perfused rat hindlimb.
Cross SE; Wu Z; Roberts MS
J Pharmacol Exp Ther; 1996 Apr; 277(1):366-74. PubMed ID: 8613943
[TBL] [Abstract][Full Text] [Related]
5. Can tissue drug concentrations be monitored by microdialysis during or after isolated limb perfusion for melanoma treatment?
Wu ZY; Smithers BM; Anderson C; Roberts MS
Melanoma Res; 2000 Feb; 10(1):47-54. PubMed ID: 10711640
[TBL] [Abstract][Full Text] [Related]
6. Reduced liver uptake of arterially infused melphalan during retrograde rat liver perfusion with unaffected liver tumor uptake.
Rothbarth J; Sparidans RW; Beijnen JH; Schultze-Kool LJ; Putter H; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2002 Nov; 303(2):736-40. PubMed ID: 12388659
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of melphalan in isolated limb perfusion.
Norda A; Loos U; Sastry M; Goehl J; Hohenberger W
Cancer Chemother Pharmacol; 1999; 43(1):35-42. PubMed ID: 9923539
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of isolated lung perfusion with melphalan for resectable pulmonary metastases, a phase I and extension trial.
Grootenboers MJ; Hendriks JM; van Boven WJ; Knibbe CA; van Putte B; Stockman B; De Bruijn E; Vermorken JB; Van Schil PE; Schramel FM
J Surg Oncol; 2007 Dec; 96(7):583-9. PubMed ID: 17999399
[TBL] [Abstract][Full Text] [Related]
9. Hyperthermia modifies pharmacokinetics and tissue distribution of intraperitoneal melphalan in a rat model.
Glehen O; Stuart OA; Mohamed F; Sugarbaker PH
Cancer Chemother Pharmacol; 2004 Jul; 54(1):79-84. PubMed ID: 15048586
[TBL] [Abstract][Full Text] [Related]
10. Isolated limb perfusion with melphalan for human melanoma xenografts in the hindlimb of nude rats: a surviving animal model.
Wu Z; Roberts MS; Parsons PG; Smithers BM
Melanoma Res; 1997 Feb; 7(1):19-26. PubMed ID: 9067961
[TBL] [Abstract][Full Text] [Related]
11. A human melanoma xenograft in a nude rat responds to isolated limb perfusion with TNF plus melphalan.
Bauer TW; Gutierrez M; Dudrick DJ; Li J; Blair IA; Menon C; Fraker DL
Surgery; 2003 Apr; 133(4):420-8. PubMed ID: 12717360
[TBL] [Abstract][Full Text] [Related]
12. Tumour necrosis factor alpha increases melphalan concentration in tumour tissue after isolated limb perfusion.
de Wilt JH; ten Hagen TL; de Boeck G; van Tiel ST; de Bruijn EA; Eggermont AM
Br J Cancer; 2000 Mar; 82(5):1000-3. PubMed ID: 10737379
[TBL] [Abstract][Full Text] [Related]
13. Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics.
Benckhuijsen C; Kroon BB; van Geel AN; Wieberdink J
Eur J Surg Oncol; 1988 Apr; 14(2):157-63. PubMed ID: 3360157
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of melphalan in isolated perfusion of the limbs.
Benckhuijsen C; Varossieau FJ; Hart AA; Wieberdink J; Noordhoek J
J Pharmacol Exp Ther; 1986 May; 237(2):583-8. PubMed ID: 3701643
[TBL] [Abstract][Full Text] [Related]
15. Regional differences of melphalan lung levels after isolated lung perfusion in the rat.
Romijn S; Hendriks JM; Van Putte BP; Weyler J; Guetens G; De Boeck G; Van Schil PE
J Surg Res; 2005 May; 125(2):157-60. PubMed ID: 15854668
[TBL] [Abstract][Full Text] [Related]
16. [Melphalan pharmacokinetics during isolated limb regional perfusion in patients with skin melanoma and soft tissue sarcoma].
Gafton GI; Senchik KY; Petrov VG; V V Semiglazov ; N V Tatyanicheva ; V G Bespalov ; Semiletova YV; Gafton IG; Zinoviev GV; Kireeva GS
Vopr Onkol; 2015; 61(6):932-6. PubMed ID: 26995981
[TBL] [Abstract][Full Text] [Related]
17. The isolated hind limb preparation as a drug distribution model.
Casquero-Dorado AC; Sánchez-Navarro A
Methods Find Exp Clin Pharmacol; 1996 Sep; 18(7):453-8. PubMed ID: 8900218
[TBL] [Abstract][Full Text] [Related]
18. Lack of glutathione conjugation of melphalan in the isolated in situ liver perfusion in humans.
Vahrmeijer AL; Snel CA; Steenvoorden DP; Beijnen JH; Pang KS; Schutrups J; Tirona R; Keizer HJ; van Dierendonck JH; van de Velde CJ; Mulder GJ
Cancer Res; 1996 Oct; 56(20):4709-14. PubMed ID: 8840988
[TBL] [Abstract][Full Text] [Related]
19. Simple high-performance liquid chromatographic assay for melphalan in perfusate, rat liver and tumour tissue.
Sparidans RW; Silvertand L; Dost F; Rothbarth J; Mulder GJ; Schellens JH; Beijnen JH
Biomed Chromatogr; 2003 Oct; 17(7):458-64. PubMed ID: 14598330
[TBL] [Abstract][Full Text] [Related]
20. Melphalan antitumor efficacy and hepatotoxicity: the effect of variable infusion duration in the hepatic artery.
Rothbarth J; Woutersen RA; Sparidans RW; van de Velde CJ; Mulder GJ
J Pharmacol Exp Ther; 2003 Jun; 305(3):1098-103. PubMed ID: 12606622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
